Title of article
2-Year Results of CoreValve Implantation Through the Subclavian Access: A Propensity-Matched Comparison With the Femoral Access
Author/Authors
Petronio، نويسنده , , Anna Sonia and De Carlo، نويسنده , , Marco and Bedogni، نويسنده , , Francesco and Maisano، نويسنده , , Francesco and Ettori، نويسنده , , Federica and Klugmann، نويسنده , , Silvio and Poli، نويسنده , , Arnaldo and Marzocchi، نويسنده , , Antonio and Santoro، نويسنده , , Gennaro and Napodano، نويسنده , , Massimo and Ussia، نويسنده , , Gian Paolo and Giannini، نويسنده , , Cristina and Brambilla، نويسنده , , Nedy and Colombo، نويسنده , , Antonio، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2012
Pages
6
From page
502
To page
507
Abstract
Objectives
al of this study was to assess the procedural and 2-year results of the subclavian approach for transcatheter aortic valve implantation (TAVI) compared with those of the femoral approach by using propensity-matched analysis.
ound
bclavian approach with the CoreValve prosthesis (Medtronic, Inc., Minneapolis, Minnesota) represents an interesting opportunity when the femoral access is unfeasible.
s
nsecutive patients enrolled in the Italian CoreValve Registry who underwent TAVI with the subclavian approach were included. Propensity score analysis was used to identify a matching group of patients undergoing femoral TAVI.
s
vian approach was used in 141 patients (61% men; median age 83 years; median logistic European System for Cardiac Operative Risk Evaluation score 23.7%). The femoral group of 141 patients was matched for baseline clinical characteristics, except for peripheral artery disease. The 2 groups showed similar procedural success (97.9% vs. 96.5%; p = 0.47), major vascular complications (5.0% vs. 7.8%; p = 0.33), life-threatening bleeding events (7.8% vs. 5.7%; p = 0.48), and combined safety endpoint (19.9% vs. 25.5%; p = 0.26). The subclavian group showed lower rates of acute kidney injury/stage 3 (4.3% vs. 9.9%; p = 0.02), of minor vascular complications at the 18-F sheath insertion site (2.1% vs. 11.3%; p = 0.003), and of all types of bleeding events related to vascular complications. Survival at 2 years was 74.0 ± 4.0% in the subclavian group compared with 73.7 ± 3.9% in the femoral group (p = 0.78). The 2-year freedom from cardiovascular death was 87.2 ± 3.1% versus 88.7 ± 2.8% in the subclavian versus femoral group, respectively (p = 0.84).
sions
bclavian approach for TAVI is safe and feasible, with procedural and medium-term results similar to the femoral approach. Subclavian access should be considered a valid option not only when the femoral approach is impossible but also when it is difficult, albeit feasible.
Keywords
subclavian , Aortic stenosis , transcatheter aortic valve implantation
Journal title
JACC (Journal of the American College of Cardiology)
Serial Year
2012
Journal title
JACC (Journal of the American College of Cardiology)
Record number
1754470
Link To Document